SEC Form D private-offering filing

ADIAL PHARMACEUTICALS, INC.

Name: ADIAL PHARMACEUTICALS, INC. - new SEC Form D private-offering filing, Glen Allen, VA
Published: 2025-12-03

A new SEC Form D private-offering notice from Glen Allen, VA, a $4,285,289 filer-stated offering target in Biotech. The source filing is one click away.

ADIAL PHARMACEUTICALS, INC. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing AD04 for alcohol use disorder and AT177 for ulcerative colitis, trades on Nasdaq as ADIL.

Filed 2025-12-03Filed to raise $4,285,289First money in 2025-11-28Raised so far $4,285,289HQ (as filed) Glen Allen, VASector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified adial.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Virginia →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.